NIG
IDXX icon

NFJ Investment Group’s Idexx Laboratories IDXX Stock Holding History

NFJ Investment Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27
Closed -$18.3K – 241
2025
Q4 		$18.3K Hold
27
– – ﹤0.01% 207
2025
Q3 		$17.3K Hold
27
– – ﹤0.01% 234
2025
Q2 		$14.5K Hold
27
– – ﹤0.01% 253
2025
Q1 		$11.3K Sell
27
-3
-10% -$1.3K ﹤0.01% 276
2024
Q4 		$12.4K Sell
30
-29,031
-100% -$12.7M ﹤0.01% 265
2024
Q3 		$14.7M Sell
29,061
-1,750
-6% -$850K 0.43% 71
2024
Q2 		$15M Sell
30,811
-11,558
-27% -$5.8M 0.46% 70
2024
Q1 		$22.9M Buy
42,369
+41,242
+3,659% +$22.5M 0.63% 57
2023
Q4 		$626K Sell
1,127
-1,386
-55% -$651K 0.02% 208
2023
Q3 		$1.1M Sell
2,513
-1,631
-39% -$813K 0.03% 191
2023
Q2 		$2.08M Sell
4,144
-40,737
-91% -$19.5M 0.06% 201
2023
Q1 		$22.4M Sell
44,881
-13,147
-23% -$6.29M 0.6% 51
2022
Q4 		$23.7M Sell
58,028
-15,705
-21% -$6.1M 0.62% 51
2022
Q3 		$21.8M Buy
+73,733
New +$27.1M 0.57% 50

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NFJ Investment Group's IDXX Position: Q1 2026 in Review

NFJ Investment Group sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 27 shares — an estimated $18.3K sold.

NFJ Investment Group first reported a position in IDXX in Q3 2022 and held it in 14 quarters. The position peaked at $23.7M in Q4 2022. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • NFJ Investment Group reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • NFJ Investment Group sold 27 Idexx Laboratories shares in Q1 2026, an estimated $18.3K.
  • NFJ Investment Group first reported a position in Idexx Laboratories in Q3 2022 and held it in 14 quarters.
  • NFJ Investment Group's Idexx Laboratories position peaked at $23.7M in Q4 2022.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on NFJ Investment Group's 13F filing for Q1 2026, filed 13 May 2026.